InChI=1S/C14H22N2O2.C4H6O6/c1- 6- 16(5) 14(17) 18- 13- 9- 7- 8- 12(10- 13) 11(2) 15(3) 4;5- 1(3(7) 8) 2(6) 4(9) 10/h7- 11H,6H2,1- 5H3;1- 2,5- 6H,(H,7,8) (H,9,10) /t11- ;1- ,2- /m01/s1 |
GWHQHAUAXRMMOT-MBANBULQSA-N |
O[C@H]([C@@H](O)C(O)=O)C(O)=O.CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C |
|
cholinergic drug
Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of acetylcholine, and drugs that affect the survival of cholinergic neurons.
EC 3.1.1.8 (cholinesterase) inhibitor
An EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of cholinesterase (EC 3.1.1.8).
|
|
cholinergic drug
Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of acetylcholine, and drugs that affect the survival of cholinergic neurons.
neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
|
|
View more via ChEBI Ontology
3- [(1S)- 1- (dimethylamino)ethyl]phenyl ethyl(methyl)carbamate (2R,3R)- 2,3- dihydroxybutanedioate
|
(1S)- 1- (3- {[ethyl(methyl)carbamoyl]oxy}phenyl)- N,N- dimethylethanaminium (2R,3R)- 3- carboxy- 2,3- dihydroxypropanoate
|
IUPAC
|
rivastigmine hydrogen tartrate
|
DrugBank
|
SDZ-ENA 713
|
ChemIDplus
|
129101-54-8
|
CAS Registry Number
|
KEGG DRUG
|
129101-54-8
|
CAS Registry Number
|
ChemIDplus
|
9305032
|
Reaxys Registry Number
|
Reaxys
|
|